Superior Memory Reduces 8-year Risk of Mild Cognitive Impairment and Dementia But Not Amyloid β-Associated Cognitive Decline in Older Adults
Author(s) -
Christa Dang,
Karra Harrington,
Yen Ying Lim,
David Ames,
Jason Hassenstab,
Simon M. Laws,
Nawaf Yassi,
Martha Hickey,
Stephanie R. RaineySmith,
Joanne Robertson,
Christopher C. Rowe,
Hamid R. Sohrabi,
Olivier Salvado,
Michael Weinborn,
Victor L. Villemagne,
Colin L. Masters,
Paul Maruff
Publication year - 2018
Publication title -
archives of clinical neuropsychology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.909
H-Index - 98
eISSN - 1873-5843
pISSN - 0887-6177
DOI - 10.1093/arclin/acy078
Subject(s) - dementia , cognition , episodic memory , psychology , cognitive decline , alzheimer's disease , hazard ratio , medicine , gerontology , disease , psychiatry , confidence interval
To prospectively examine 8-year risk of clinical disease progression to mild cognitive impairment (MCI)/dementia in older adults ≥60 with superior episodic memory (SuperAgers) compared to those cognitively normal for their age (CNFA). Additionally, to determine the extent to which SuperAgers were resilient to the negative effects of elevated amyloid-beta (Aβ+) on cognition.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom